WHO to back use of weight-loss drugs for adults globally, raises cost issue

Real-time Estimate Cboe BZX			5-day change	1st Jan Change
822.08 ^USD	-8.55%		-3.05%	+7.97%

Published on 05/01/2025 at 11:00

This article is reserved for members

Unlock the article: REGISTER NOW!

Exclusive-WHO to back use of weight-loss drugs for adults globally, raises cost issue	11:00am	RE
WHO to back use of weight-loss drugs for adults globally, raises cost issue	11:00am	RE
Eli Lilly’s strong quarter undercut by CVS move to drop Zepbound coverage	10:46am	RE
Eli Lilly’s strong quarter undercut by CVS move to drop Zepbound coverage	10:46am	RE
Nasdaq leads gains on Wall Street as Microsoft, Meta surge	10:29am	RE
CVS raises profit forecast, to exit Obamacare market as turnaround gains steam	09:59am	RE
Sector Update: Health Care Stocks Mixed Premarket Thursday	09:12am	MT
Eli Lilly Lowers 2025 Earnings Outlook Despite Stronger-Than-Expected First-Quarter Results	09:07am	MT
Wall Street set for strong open as Microsoft, Meta soar	09:05am	RE
Sector Update: Health Care	08:54am	MT
Stocks Rise Pre-Bell Following Upbeat Microsoft, Meta Results; Investors Await More Tech Earnings	07:37am	MT
US stock futures jump as Microsoft, Meta climb after results	07:29am	RE
Tech Earnings Drive Wall Street Up Pre-Bell; Asia, Europe Gain	07:29am	MT
Eli Lilly 1Q Revenue Surges on Demand for Mounjaro, Other Weight-Loss Treatments	07:25am	DJ
Eli Lilly Q1 Non-GAAP Earnings, Revenue Rise; 2025 Earnings Guidance Trimmed	07:07am	MT
Eli Lilly beats Q1 profit estimates on strength of diabetes drug	06:55am	RE
(LLY) Eli Lilly and Co. Forecasts Fiscal Year 2025 Adjusted EPS Range $20.78 – $22.28	06:48am	MT
Earnings Flash (LLY) Eli Lilly and Co. Posts Q1 Revenue $12.73B, vs. FactSet Est of $12.67B	06:48am	MT
Earnings Flash (LLY) Eli Lilly and Co. Posts Q1 Adjusted EPS $3.34, vs. FactSet Est of $3.26	06:47am	MT
Eli Lilly and Company Reports Earnings Results for the First Quarter Ended March 31, 2025	06:45am	CI
Eli Lilly and Company Reaffirms Earnings Guidance for the Year 2025	06:45am	CI
Equity Markets Close Higher Despite Weak Labor, Consumer Confidence Signals	Apr. 29	MT
Sector Update: Consumer Stocks Rise in Late Afternoon	Apr. 29	MT
Sector Update: Consumer	Apr. 29	MT
Top Midday Gainers	Apr. 29	MT

Duration

Period

LLY: Dynamic Chart

Eli Lilly and Company is one of the world’s leading pharmaceutical groups. Net sales break down by therapeutic field as follows:

– endocrinology (65.5%): products for treating osteoporosis, diabetes, and growth problems;

– oncology (19.4%);

– immunology diseases (9.8%);

– neurology (3.3%): primarily drugs used in treating depression and schizophrenia;

– other (2%).

Net sales are distributed geographically as follows: the United States (67.4%), Europe (15.4%), Japan (4%), China (3.7%) and other (9.5%).

More about the company

Sell

Buy

Last Close Price

898.95USD

Average target price

991.97USD

Spread / Average Target

+10.35%

Consensus

Exclusive-US Health Secretary Kennedy to address Gavi vaccine event amid funding pullback

Tesla seeks to keep Texas robotaxi data under wraps, regulator says

Oil prices are now the stock market’s biggest driver

Tesla shares soar after first robotaxi rides hit the road in Austin, Texas

Fed’s Bowman open to cutting rates at July policy meeting

Fiserv shares rise on stablecoin launch plans

Top Premarket Decliners | MarketScreener

Commercial Metals misses Q3 revenue estimates

Amazon’s premium beauty push may be a buffer against Trump’s tariffs

Bitcoin removes pressure from USD

Bitcoin And Ethereum Coinbase Premium Remains Positive For 7 Weeks — Here’s Why — TradingView News

Wall Street rocked by heavyweight slugfest as investment titan bets the house against rival’s $100BN company

Ethereum Historical Pattern Hints At Potential $10,000 Surge

Retail Trading Giant Robinhood Rolling Out Micro Futures for Bitcoin, Solana and XRP

Google’s Gemini AI Predicts the Price of XRP, Pi Coin and Bitcoin Cash by the End of 2025 — TradingView News

Exclusive-US Health Secretary Kennedy to address Gavi vaccine event amid funding pullback

Tesla seeks to keep Texas robotaxi data under wraps, regulator says

Oil prices are now the stock market’s biggest driver

Tesla shares soar after first robotaxi rides hit the road in Austin, Texas

Fed’s Bowman open to cutting rates at July policy meeting

Fiserv shares rise on stablecoin launch plans

Top Premarket Decliners | MarketScreener

Commercial Metals misses Q3 revenue estimates

Amazon’s premium beauty push may be a buffer against Trump’s tariffs

Bitcoin removes pressure from USD

Bitcoin And Ethereum Coinbase Premium Remains Positive For 7 Weeks — Here’s Why — TradingView News

Wall Street rocked by heavyweight slugfest as investment titan bets the house against rival’s $100BN company

Ethereum Historical Pattern Hints At Potential $10,000 Surge

Retail Trading Giant Robinhood Rolling Out Micro Futures for Bitcoin, Solana and XRP

Google’s Gemini AI Predicts the Price of XRP, Pi Coin and Bitcoin Cash by the End of 2025 — TradingView News

WHO to back use of weight-loss drugs for adults globally, raises cost issue

Related Posts

Bitcoin removes pressure from USD

Bitcoin And Ethereum Coinbase Premium Remains Positive For 7 Weeks — Here’s Why — TradingView News

Wall Street rocked by heavyweight slugfest as investment titan bets the house against rival’s $100BN company

Cardano holds key support as developer activity tops Ethereum

Tech sector surges: Nvidia and Microsoft lead today's market gains

bitcoin price 2025: Bitcoin approaches $95K: Is it heading towards $100K? Ethereum, XRP, and Altcoins shine in 2025; here's what numbers are telling

Recent Posts

Navigate Site

WHO to back use of weight-loss drugs for adults globally, raises cost issue

Related Posts

Recent Posts

Navigate Site

Follow Us